高级检索
当前位置: 首页 > 详情页

Effects of patency of infarct-related coronary artery on acute outcome in acute myocardial infarction patients undergoing urokinase therapy

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ 中华系列

单位: [1]FUWAI HOSP, PUMC, BEIJING 100037, PEOPLES R CHINA [2]BEIJING EMERGENCY MED CTR, BEIJING, PEOPLES R CHINA [3]CHINESE MED UNIV, AFFILIATED HOSP 1, SHENYANG, PEOPLES R CHINA [4]DEZHOU HOSP, DEZHOU, PEOPLES R CHINA [5]BEIJING MED UNIV, AFFILIATED HOSP 3, BEIJING, PEOPLES R CHINA [6]TIANJIN MED UNIV, GEN HOSP, TIANJIN, PEOPLES R CHINA [7]NANJING HOSP 1, NANJING, PEOPLES R CHINA [8]HAERBIN HOSP 1, HAERBIN, PEOPLES R CHINA [9]HAERBIN MED UNIV, AFFILIATED HOSP 1, HAERBIN, PEOPLES R CHINA [10]BEIJING FRIENDSHIP HOSP, BEIJING, PEOPLES R CHINA [11]SHENYANG GEN HOSP, SHENYANG, PEOPLES R CHINA [12]BEIJING RES GROSS CHAO YANG HOSP, BEIJING, PEOPLES R CHINA [13]BEIJING ANZHEN HOSP, BEIJING, PEOPLES R CHINA [14]PLA, GEN HOSP, BEIJING, PEOPLES R CHINA [15]SHANXI MED UNIV, AFFILIATED HOSP 1, TAIYUAN, PEOPLES R CHINA [16]BEIJING XUAN WU HOSP, BEIJING, PEOPLES R CHINA [17]BEIJING JI SHI TAN HOSP, BEIJING, PEOPLES R CHINA [18]JIN ZHOU HOSP 1, JIN ZHOU, PEOPLES R CHINA [19]TONG JI MED UNIV, TONG JI HOSP, WUHAN, PEOPLES R CHINA [20]TIANJIN RAILWAY CENT HOSP, TIANJIN, PEOPLES R CHINA [21]DALIAN MED UNIV, AFFILIATED HOSP 1, DALIAN, PEOPLES R CHINA [22]TIANJIN CHEST HOSP, TIANJIN, PEOPLES R CHINA [23]FOURTH MIL MED UNIV, XIJING AFFILIATED HOSP, XIAN, PEOPLES R CHINA [24]PEKING UNION COLL HOSP, CAMS, BEIJING, PEOPLES R CHINA [25]PEKING UNION COLL HOSP, PUMC, BEIJING, PEOPLES R CHINA [26]ANSHAN STEEL & IRON COMPANCY, TIEDONG HOSP, ANSHAN, PEOPLES R CHINA [27]BEIJING FU XING HOSP, BEIJING, PEOPLES R CHINA [28]BEIJING BLDG ENGN GEN HOSP, BEIJING, PEOPLES R CHINA [29]LANGFANG HOSP, LANGFANG, PEOPLES R CHINA [30]CHINA JAPAN FRIENDSHIP HOSP, BEIJING, PEOPLES R CHINA [31]PLA, 304TH HOSP, BEIJING, PEOPLES R CHINA [32]DALIAN MED UNIV, AFFILIATED HOSP 2, DALIAN, PEOPLES R CHINA [33]BEIJING POST TELECON GEN HOSP, BEIJING, PEOPLES R CHINA [34]HENAN MED UNIV, AFFILIATED HOSP 1, ZHENGZHOU, PEOPLES R CHINA [35]YANTAI YU HUANG DING HOSP, YANTAI, PEOPLES R CHINA [36]PLA, NAVY GEN HOSP, BEIJING, PEOPLES R CHINA [*1]FUWAI HOSP, CAMS, BEIJING 100037, PEOPLES R CHINA
出处:
ISSN:

摘要:
Objective To study the effects of patency of infarct-related coronary artery on acute outcome in cases of acute myocardial infarction undergoing urokinase therapy. Methods One thousand one hundred and thirty-eight cases of acute myocardial infarction admitted in 37 collaborative hospitals were given urokinase intravenously with a standard program. Patency of infarct-related coronary artery assessed by uniform criteria occurred in 757 patients (66.5%) and non-patency in 381 patients (33.5%). Four-week mortality and frequency of various severe complications were compared between patency patients and non-patency patients. Results The 4-week mortality in patients with patency was 3.4% versus 21.8% in those without patency (P < 0.001). Frequencies of various severe complications such as heart failure, shock, ventricular fibrillation, bundle branch blocks and mechanical complications (P < 0.01), and complete atrioventricular block (P < 0.05) were much higher in patients without than in those with patency. In large sized infarcts such as high lateral plus anterior wall infarction the difference in 4 week mortality was even more obvious between patients with and without patency (2.6% vs 32.7%, P < 0.001). Using Cox proportional hazards regression model analysis, patency of infarct-related coronary artery was defined as the most important independent predictor of 4-week mortality. The risk ratio for occluded versus parent infarct-related coronary artery was 6.69. Conclusion On univariate and multivariate analyses, patency of the infarct-related coronary artery was the most important prognostic factor for acute outcome in acute myocardial infarction.

语种:
WOS:
中科院(CAS)分区:
出版当年[1996]版:
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
JCR分区:
出版当年[1995]版:
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[1995版] 出版当年五年平均[1991-1995] 出版前一年[1994版]

第一作者:
第一作者单位: [*1]FUWAI HOSP, CAMS, BEIJING 100037, PEOPLES R CHINA
通讯作者:
通讯机构: [*1]FUWAI HOSP, CAMS, BEIJING 100037, PEOPLES R CHINA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)